KRAS c.305G>C ;(p.R102T)

Variant ID: 12-25378693-C-G

NM_004985.3(KRAS):c.305G>C;(p.R102T)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience.

Gynecologic Oncology Research And Practice
Fu, Siqing S; Shi, Naiyi N; Wheler, Jennifer J; Naing, Aung A; Janku, Filip F; Piha-Paul, Sarina S; Gong, Jing J; Hong, David D; Tsimberidou, Apostolia A; Zinner, Ralph R; Subbiah, Vivek V; Hou, Ming-Mo MM; Ramirez, Pedro P; Ramondetta, Lois L; Lu, Karen K; Meric-Bernstam, Funda F
Publication Date: 2015

Variant appearance in text: KRAS: R102T
PubMed Link: 27231570
Variant Present in the following documents:
  • Main text
  • 40661_2015_Article_18.pdf
View BVdb publication page